Bayer targets mid-20% EBITDA margin and above-market growth by 2029
Bayer says it is targeting above-market growth and a mid-20% CEBITDA margin by 2029, citing progress in margin, sales and cash flow initiatives.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Bayer says it is targeting above-market growth and a mid-20% CEBITDA margin by 2029, citing progress in margin, sales and cash flow initiatives.